Media center
COMUNICATO STAMPA – Waldo Mossi eletto Vicepresidente di Farma Industria Ticino per il triennio 2022-2025
![](https://www.farmaindustriaticino.ch/files/2021/12/Schermata-2021-12-20-alle-12.05.09-160x160.png)
The 3rd Sustainability Report confirms IBSA’s commitment to the well-being of the Person
![](https://www.farmaindustriaticino.ch/files/2021/11/Schermata-2021-11-26-alle-09.43.33-160x160.png)
Intervista al Presidente FIT Giorgio Calderari, Falò RSI La 1, giovedì 25 novembre 2021
![](https://www.farmaindustriaticino.ch/files/2021/11/9A98CCAF-D379-40CB-B840-759AB4CD686B-160x160.jpeg)
Farma Industria Ticino in Milan for CPhI 2021, 9-11 November 2021
![](https://www.farmaindustriaticino.ch/files/2021/09/IMG_5496-160x160.jpg)
41a Assemblea generale ordinaria di Farma Industria Ticino
![](https://www.farmaindustriaticino.ch/files/2021/04/Schermata-2021-04-30-alle-09.07.37-160x160.png)
Lonza raddoppia la produzione di vaccini – Intervista al Presidente di FIT Giorgio Calderari
![](https://www.farmaindustriaticino.ch/files/2019/10/15-IBSA-1-160x160.jpg)
DA IBSA OLTRE 700.000 CHF PER COMBATTERE L’EMERGENZA COVID-19 DI QUESTI 245.000 CHF DONATI DAI LAVORATORI IBSA A SOSTEGNO DELLE FAMIGLIE IN DIFFICOLTÀ
![](https://www.farmaindustriaticino.ch/files/2017/02/logo_helsinn-160x160.png)
Helsinn and MEI Pharma Announce Updated Clinical Data from the Phase 2 Study Evaluating Pracinostat in Combination with Azacitidine in Patients with High/Very-high Risk Myelodysplastic Syndromes
![](https://www.farmaindustriaticino.ch/files/2019/10/15-IBSA-1-160x160.jpg)
Linkedin